Efficacy and Safety of Delayed Prolonged-Release Tacrolimus Initiation in De Novo Hepatitis C Virus-Negative Orthotopic Liver Transplant Recipients: A Single-Center, Single-Arm, Prospective Study

Laura Lladó; Ana González-Castillo; Joan Fabregat; Carme Baliellas; Emilio Ramos; Emma González-Vilatarsana; Juli Busquets; Xavier Xiol

doi:10.12659/AOT.912444

18 January 2019 : Original article

Efficacy and Safety of Delayed Prolonged-Release Tacrolimus Initiation in De Novo Hepatitis C Virus-Negative Orthotopic Liver Transplant Recipients: A Single-Center, Single-Arm, Prospective Study

Laura Lladó^{BDE 1*}, Ana González-Castillo^{BDE 1}, Joan Fabregat^{BDE 1}, Carme Baliellas^{BDE 1}, Emilio Ramos^{BDE 1}, Emma González-Vilatarsana^{BDE 1}, Juli Busquets^{BDE 1}, Xavier Xiol^{BDE 1}

DOI: 10.12659/AOT.912444

Ann Transplant 2019; 24:36-44

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

Efficacy and Safety of Delayed Prolonged-Release Tacrolimus Initiation in De Novo Hepatitis C Virus-Negative Orthotopic Liver Transplant Recipients: A Single-Center, Single-Arm, Prospective Study

Your Privacy